Y-MABS THERAPEUTICS INC (YMAB)
US9842411095 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to YMAB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 21.86. This target is 27.45% above the current price.
YMAB was analyzed by 13 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about YMAB.
In the previous month the buy percentage consensus was at a similar level.
YMAB was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-04 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-03-04 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-02-20 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-22 | JP Morgan | Maintains | Underweight -> Underweight |
| 2023-08-14 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2023-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-25 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2023-06-07 | Canaccord Genuity | Reiterate | Buy -> Buy |
| 2023-05-15 | B of A Securities | Maintains | Neutral -> Neutral |
| 2023-05-10 | Wedbush | Upgrade | Neutral -> Outperform |
| 2023-05-10 | Morgan Stanley | Maintains | Underweight |
| 2023-05-09 | Canaccord Genuity | Maintains | Buy |
| 2023-04-04 | HC Wainwright & Co. | Maintains | Buy |
| 2023-04-03 | Guggenheim | Downgrade | Buy -> Neutral |
| 2023-03-31 | Canaccord Genuity | Maintains | Buy |
| 2023-01-30 | BMO Capital | Maintains | Outperform |
| 2023-01-27 | Morgan Stanley | Downgrade | Equal-Weight -> Underweight |
| 2023-01-05 | Cowen & Co. | Downgrade | Outperform -> Market Perform |
| 2022-12-02 | B of A Securities | Downgrade | Buy -> Neutral |
| 2022-11-01 | BMO Capital | Maintains | Outperform |
| 2022-10-31 | Wedbush | Downgrade | Outperform -> Neutral |
| 2022-10-31 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2022-10-31 | Canaccord Genuity | Maintains | Buy |
| 2022-10-31 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-10-31 | HC Wainwright & Co. | Maintains | Buy |
| 2022-09-09 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-06-24 | BMO Capital | Initiate | Outperform |
| 2022-02-28 | HC Wainwright & Co. | Maintains | Buy |